The largest community of pharma leaders

World’s Leading Home Improvement Retailer Battling COVID-19 Impact with Reality Interactive

MIDDLETOWN, Conn.–()–Reality Interactive, a leading retail technology design firm and digital agency in Middletown, Connecticut, announced the launch of its AXSIS™ Thermal Enabled Digital Hub. The leading home improvement retailer in the world has already deployed 6,000 units, showing that the AXSIS™ device is exactly what employers are looking for to get the job done when it comes to keeping people safe in 2020 and beyond.

While Connecticut has recently entered into Phase III of its COVID-19 re-entry plan, both the state and the country are still acutely aware that the pandemic is still impacting business and health. With winter months on the horizon, companies are searching for ways to ensure they can safely keep their business thriving.

The AXSIS™ device is a proprietary thermo-scanner and data hub that provides a 100% contactless body temperature check in just seconds. This level of real-time, accurate data capture not only helps keep the workforce and customers safe, but also gives management a comprehensive view of the day-to-day health status of their employee population.

The AXSIS™ Thermal Enabled Digital Hub can be used as a standalone device, but Reality Interactive sees a bigger, more holistic picture. “These are very uncertain times, and so it’s been invaluable to be able to use technology like this to provide some peace of mind,” said Mitch DeBonville, Director of Sales at Reality Interactive. “It’s part of our efforts to help our clients keep people safe and healthy.”

Reality Interactive continues to work on additional features that will elevate this already industry-leading technology. For example, a fully customizable option that allows the customer to control an existing door lock system in real-time, and access a back-end portal with usage data and analytics. The AXSIS™ device also syncs with the agency’s bitSHUTTLE® content management platform, allowing real-time updates to be triggered in a rapidly changing environment, including a post COVID-19 world. “The AXSIS™ device will retain its relevancy because it goes well beyond just thermal scanning, helping employers better manage their ongoing staffing and productivity needs, safely,” said Mitch DeBonville.

Reality Interactive initially developed the product within its own headquarters as an initiative to help keep employees safe beyond social distancing measures. Upon seeing the reassurance this provided both employees and customers, the company was selected to work with this industry giant’s stores nationwide, helping thousands of employees safely get back to work.

Book a demo or learn more at www.realityi.com/axsis.

About Reality Interactive

Reality Interactive is a multi-award winning, retail technology and design agency. The firm specializes in creating and managing innovative retail experiences using touchscreen displays, digital signage, digital media and a full suite of interactive and creative technologies.

Over the past 16 years, Reality has created hundreds of dynamic in-store experiences partnering with some of the world’s biggest brands and their agencies.

Source

Recent Articles

PHARMACEUTICAL TECHNOLOGY: Is quantum computing pharma’s next big disruptor?

Quantum computing is the next frontier in the field of IT. One industry that is set to benefit significantly from the development of these...

BIO: Trump’s Revenge on Pharma

The Trump administration unveiled a new drug price control policy, drawing opposition from pharma manufacturers and pharmacy benefit managers. In unveiling a set of drug...

Global Genes Honors Leaders, Advocates, and Innovators in Rare Disease From Around the World at the 2020 RARE Champion of Hope Celebration

Global Genes, a leading rare disease patient advocacy organization, announces eight award recipients ⁠of diverse backgrounds and experiences through its annual Champion of Hope...

FDA to make emergency use authorization data public for COVID-19 vaccines

(Reuters) - The U.S. Food and Drug Administration said on Tuesday it would make public reviews of all data and information regarding the emergency...

U.S. FDA declines to approve Alkermes’ schizophrenia treatment

(Reuters) - The U.S. Food and Drug Administration did not approve Alkermes’ treatment for schizophrenia and bipolar disorder, the drugmaker said on Tuesday. Following a...